Womens Health

GLP-1 and Heart Health for Women Over 50: What You Need to Know

If you're a woman over 50, you've probably heard about GLP-1 medications for weight loss. But here's what might surprise you: these medications may offer significant protection for your heart at a time when cardiovascular risk naturally increases. As estrogen levels decline during and after menopause, women face a sharp rise in heart disease risk. Understanding how GLP-1 therapy intersects with cardiovascular health could be one of the most important conversations you have with your doctor.

Why Heart Health Becomes Critical for Women After 50

Before menopause, estrogen provides natural cardiovascular protection. It helps keep blood vessels flexible, maintains healthy cholesterol levels, and reduces inflammation throughout the body.

But as estrogen declines, the protection fades. Heart disease becomes the leading cause of death for women over 50, eventually surpassing the risk in men of similar ages. The shift happens relatively quickly, often within the first decade after menopause.

Women also tend to experience heart disease differently than men, with symptoms that are easier to miss and outcomes that can be more severe when diagnosis is delayed.

How GLP-1 Medications Support Cardiovascular Health

GLP-1 receptor agonists like semaglutide and tirzepatide were initially developed to manage blood sugar in people with type 2 diabetes. But researchers discovered something unexpected: these medications were protecting patients' hearts in ways that went beyond glucose control alone.

Direct Cardiovascular Benefits

Major clinical trials have demonstrated that GLP-1 medications reduce the risk of major cardiovascular events, including heart attack and stroke. The SUSTAIN-6 trial showed that semaglutide reduced cardiovascular events by 26% in high-risk patients.

These benefits appear to come through multiple pathways. GLP-1 medications reduce inflammation in blood vessel walls, improve endothelial function (how well blood vessels dilate and contract), and may directly protect heart muscle cells.

Indirect Benefits Through Metabolic Improvements

GLP-1 therapy also supports heart health by addressing multiple cardiovascular risk factors simultaneously:

What Women Over 50 Should Know

The cardiovascular benefits of GLP-1 medications are particularly relevant for women navigating the metabolic changes that come with menopause.

The Menopause-Metabolism Connection

During the menopause transition, many women experience weight gain, particularly around the midsection. This visceral fat is metabolically active and particularly harmful to cardiovascular health.

Insulin resistance also tends to increase during this time, raising the risk of developing type 2 diabetes. Blood pressure may creep up, and cholesterol profiles often shift in an unfavorable direction.

GLP-1 medications address these interconnected issues at once, making them particularly valuable during this life stage.

Gender Differences in Response

Research suggests that women may actually respond as well or better than men to GLP-1 therapy in terms of weight loss and metabolic improvements. Some studies show women achieve greater weight reduction at equivalent doses.

However, women are also more likely to experience certain side effects, particularly nausea. Working with a knowledgeable healthcare provider to find the right dose and titration schedule can make treatment much more tolerable.

Beyond the Heart: Additional Benefits

While cardiovascular protection is significant, GLP-1 medications may offer other advantages for women over 50.

Emerging research suggests potential benefits for cognitive health, with some studies indicating reduced risk of dementia. There's also evidence of kidney protection, important since kidney disease risk increases with age and is often connected to diabetes and high blood pressure.

For women dealing with polycystic ovary syndrome (PCOS) or metabolic syndrome, GLP-1 therapy addresses multiple aspects of these complex conditions.

Important Considerations

GLP-1 medications are powerful tools, but they're not appropriate for everyone. They're not recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2.

Common side effects include nausea, constipation, and decreased appetite. These typically improve over time, especially with gradual dose increases.

Cost can be a barrier when insurance doesn't cover these medications for weight management. That's why compounded versions have become an accessible option for many patients, offering the same active ingredients at a fraction of the price.

Who Should Consider GLP-1 Therapy

Women over 50 who might benefit from GLP-1 medications include those with:

The decision should be made in partnership with a healthcare provider who understands your complete medical history and can monitor your progress.

From the Ozari Care Team

Starting a GLP-1 medication during or after menopause can be particularly effective for cardiovascular protection. We recommend discussing your personal heart disease risk factors with your provider, including family history and lipid levels. Many of our patients over 50 find that combining GLP-1 therapy with strength training helps preserve muscle mass during weight loss, supporting both metabolic and bone health during this transition.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026